Solcoderm in the treatment of solar and seborrheic keratoses.
Solcoderm treatment was applied to 46 patients with solar keratosis and 40 with seborrheic keratosis. Evaluation at regular follow-up over a 10-week period showed disappearance of the lesions without any remnant in most cases. Treatment was found to be effective, convenient, and with essentially no side effects.
D000085:Acetates / Q000009:adverse effects / Q000627:therapeutic use; D019342:Acetic Acid; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols; D002986:Clinical Trials as Topic; D003300:Copper / Q000009:adverse effects / Q000627:therapeutic use; D012628:Dermatitis, Seborrheic / Q000150:complications*; D003879:Dermatologic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004338:Drug Combinations / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007642:Keratosis / Q000188:drug therapy* / Q000209:etiology; D007773:Lactates / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009566:Nitrates / Q000009:adverse effects / Q000627:therapeutic use; D011230:Precancerous Conditions / Q000188:drug therapy; D013472:Sunlight / Q000009:adverse effects*
D000085:Acetates; D003879:Dermatologic Agents; D004338:Drug Combinations; D007773:Lactates; D009566:Nitrates; D003300:Copper; D019342:Acetic Acid